STOCK TITAN
  1. Home
  2. Sec-filings
  3. TPST
  4. [EFFECT] Tempest Therapeutics, Inc. SEC Filing

[EFFECT] Tempest Therapeutics, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 3, 2026 4:00 P.M.
Form: S-3
CIK: 0001544227
Company Name: Tempest Therapeutics, Inc.
File Number: 333-294740

Source: View Original Filing on SEC EDGAR

Tempest Therapeutics Inc

NASDAQ:TPST

View TPST Stock Overview →

TPST Rankings

#6081 Ranked by Market Cap
N/A Ranked by Dividends

TPST Latest News

Mar 30, 2026
Tempest Reports Year End 2025 Financial Results and Provides Business Update
Mar 23, 2026
Tempest Therapeutics Announces Up To $6 Million Private Placement
Mar 11, 2026
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
Feb 25, 2026
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
Feb 11, 2026
Tempest Lays Out Strategic Plan to Advance Recently Acquired Dual-Targeting CAR-T Assets

TPST Latest SEC Filings

Apr 2, 2026
[Form 4] Tempest Therapeutics, Inc. Insider Trading Activity
Apr 2, 2026
[Form 4] Tempest Therapeutics, Inc. Insider Trading Activity
Apr 2, 2026
[SCHEDULE 13D/A] Tempest Therapeutics, Inc. Amended Major Shareholder Report
Apr 1, 2026
[S-3] Tempest Therapeutics, Inc. Shelf Registration Statement
Mar 30, 2026
[S-3] Tempest Therapeutics, Inc. Shelf Registration Statement

TPST Stock Data

22.81M
9.27M
Biotechnology
Pharmaceutical Preparations
Link
United States
BRISBANE